Diagnostic Accuracy of Blood Biomarkers for Alzheimer's Disease and Amnestic Mild Cognitive Impairment: A Systematic Review and Meta-Analysis

CONCLUSIONS: We suggest that blood-based biomarkers are minimally invasive and cost-effective tools for detecting AD; however, the evidence for detecting aMCI was still limited.PMID:34391944 | DOI:10.1016/j.arr.2021.101446

Source: Ageing Research Reviews - August 15, 2021 Category: Genetics & Stem Cells Authors: Ying-Ren Chen Chih-Sung Liang Hsin Chu Joachim Voss Xiao Linda Kang Grant O'Connell Hsiu-Ju Jen Doresses Liu Shu-Tai H Shen Kuei-Ru Chou Source Type: research